Tatyana Domostroeva

Medical center "Neuroprofi" LLC

SCHOLARLY PAPERS

1

DOWNLOADS

444

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (1)

1.

Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19

Number of pages: 19 Posted: 26 Oct 2020
The Federal Service on Customers' Rights Protection and Human Well-being Surveillance - Gabrichevsky Research Institute for Epidemiology and Microbiology, The Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing - Clinical Research Department, The Federal Service on Customers' Rights Protection and Human Well-being Surveillance - Gabrichevsky Research Institute for Epidemiology and Microbiology, The Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing - Clinical Research Department, Medical Center "Eco-safety", Medical Center "Group of companies "MEDSI" JSC, Medical Center "Group of companies "MEDSI" JSC, Medical Center "Group of companies "MEDSI" JSC, Budgetary Institution of Healthcare of Moscow region "Clinical Hospital of Zhukovsky" - Clinical Pharmacology Department, Medical center "Neuroprofi" LLC, Medical center "Neuroprofi" LLC, State Budgetary Institution of Healthcare of Moscow city “City Clinical Hospital No. 67 named after L.А. Vorokhobov of the Moscow City Healthcare Department”, State Budgetary Institution of Healthcare of Moscow city “City Clinical Hospital No. 67 named after L.А. Vorokhobov of the Moscow City Healthcare Department”, State Budgetary Institution of Healthcare of Moscow city “City Clinical Hospital No. 52 of the Moscow City Healthcare Department”, State Budgetary Institution of Healthcare of Moscow city “City Clinical Hospital No. 52 of the Moscow City Healthcare Department”, State Budgetary Institution of Healthcare of Moscow city “City Clinical Hospital No. 52 of the Moscow City Healthcare Department”, State Budgetary Healthcare Institution of Moscow city "Infectious Clinical Hospital No. 1 of the Moscow City Healthcare Department", State Budgetary Healthcare Institution of Moscow city "Infectious Clinical Hospital No. 1 of the Moscow City Healthcare Department", Budgetary Healthcare Institution of the Voronezh region “Voronezh Regional Clinical Hospital No. 1”, Budgetary Healthcare Institution of the Voronezh region “Voronezh Regional Clinical Hospital No. 1”, St. Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny District", St. Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny District", Federal State Budgetary Institution “National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Health of the Russian Federation, Federal State Budgetary Institution “National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Health of the Russian Federation, Federal State Autonomous Institution “N.N. Burdenko National Medical Research Centr of Neurosurgery” of the Ministry of Health of the Russian Federation, R-Pharm Group of Companies, R-Pharm Group of Companies, R-Pharm Group of Companies, R-Pharm Group of Companies, R-Pharm Group of Companies and R-Pharm Group of Companies
Downloads 444 (120,776)
Citation 6

Abstract:

Loading...

coronavirus disease, COVID-19, SARS-CoV-2 virus, favipiravir, phase 3 study